Bavarian Nordic A/S - ESG Rating & Company Profile powered by AI
The ESG assessment for Bavarian Nordic A/S indicates its reporting of the UN SDGs. If you work at Bavarian Nordic A/S and you wish to licence your Sustainability rating, please get in touch. Alternative corporations in the scoring industry group for Bavarian Nordic A/S are displayed below.
Bavarian Nordic A/S in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.2; made up of an environmental score of 3.4, social score of 5.0 and governance score of 7.0.
5.2
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 912 | Vivanza Biosciences Ltd | 5.3 | High |
| 912 | ValiRx PLC | 5.3 | High |
| 958 | Bavarian Nordic A/S | 5.2 | High |
| 958 | Altimmune Inc | 5.2 | High |
| 958 | Agios Pharmaceuticals Inc | 5.2 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Bavarian Nordic A/S have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Bavarian Nordic A/S disclose current and historical energy intensity?
Sign up for free to unlockDoes Bavarian Nordic A/S report the average age of the workforce?
Sign up for free to unlockDoes Bavarian Nordic A/S reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Bavarian Nordic A/S disclose its ethnicity pay gap?
Sign up for free to unlockDoes Bavarian Nordic A/S disclose cybersecurity risks?
Sign up for free to unlockDoes Bavarian Nordic A/S offer flexible work?
Sign up for free to unlockDoes Bavarian Nordic A/S have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Bavarian Nordic A/S disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Bavarian Nordic A/S conduct supply chain audits?
Sign up for free to unlockDoes Bavarian Nordic A/S disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Bavarian Nordic A/S conduct 360 degree staff reviews?
Sign up for free to unlockDoes Bavarian Nordic A/S disclose the individual responsible for D&I?
Sign up for free to unlockDoes Bavarian Nordic A/S disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Bavarian Nordic A/S disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Bavarian Nordic A/S disclose water use targets?
Sign up for free to unlockDoes Bavarian Nordic A/S have careers partnerships with academic institutions?
Sign up for free to unlockDid Bavarian Nordic A/S have a product recall in the last two years?
Sign up for free to unlockDoes Bavarian Nordic A/S disclose incidents of discrimination?
Sign up for free to unlockDoes Bavarian Nordic A/S allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Bavarian Nordic A/S issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Bavarian Nordic A/S disclose parental leave metrics?
Sign up for free to unlockDoes Bavarian Nordic A/S disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Bavarian Nordic A/S disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Bavarian Nordic A/S disclose the pay ratio of women to men?
Sign up for free to unlockDoes Bavarian Nordic A/S support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Bavarian Nordic A/S disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Bavarian Nordic A/S reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Bavarian Nordic A/S involved in embryonic stem cell research?
Sign up for free to unlockDoes Bavarian Nordic A/S disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Bavarian Nordic A/S disclose its waste policy?
Sign up for free to unlockDoes Bavarian Nordic A/S report according to TCFD requirements?
Sign up for free to unlockDoes Bavarian Nordic A/S disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Bavarian Nordic A/S disclose energy use targets?
Sign up for free to unlockDoes Bavarian Nordic A/S disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Bavarian Nordic A/S have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Bavarian Nordic A/S
These potential risks are based on the size, segment and geographies of the company.
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name. It is also developing MVA-BN (freeze-dried) that has completed Phase III clinical trials for the treatment of smallpox; MVA-BN RSV, which is in Phase III clinical trials for the treatment of respiratory syncytial virus; ABNCoV2 that has completed Phase II clinical trial for the treatment of SARS-CoV-2; and TAEK-VAC, which is in Phase I/II clinical trial for treatment of advanced HER2 and brachyury-expressing cancers. It has license and collaboration agreement with AdaptVac; and license agreements with National Cancer Institute and Public Health Service. The company operates in the United States, Belgium, Germany, the Netherlands, Sweden, Switzerland, Austria, the United Kingdom, Japan, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark.